OKAI — EvokAI Creative Labs Income Statement
0.000.00%
Last trade - 00:00
- CA$9.89m
- CA$9.90m
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Total Revenue | 0 | 0 | 0 | 0 | 0 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 0.081 | 0.089 | 0.086 | 0.472 | 15 |
Operating Profit | -0.081 | -0.089 | -0.086 | -0.472 | -15 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -0.081 | -0.089 | -0.086 | -0.472 | -17.1 |
Net Income After Taxes | -0.081 | -0.089 | -0.086 | -0.472 | -17.1 |
Net Income Before Extraordinary Items | |||||
Net Income | -0.081 | -0.089 | -0.086 | -0.472 | -17.1 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -0.081 | -0.089 | -0.086 | -0.472 | -17.1 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.011 | -0.012 | -0.012 | -0.06 | -0.065 |